Cowboys owner Jerry Jones reveals he battled Stage 4 melanoma: ‘I now have no tumors’
- Share via
See more from the L.A. Times in Google Search. Set us as preferred
Jerry Jones was diagnosed with Stage 4 melanoma in 2010 but overcame it with the help of an experimental trial drug, the Dallas Cowboys owner revealed this week.
“I was saved by a fabulous treatment and great doctors and a real miracle [drug] called PD-1 [therapy],” Jones told the Dallas Morning News on Tuesday. “I went into trials for that PD-1 and it has been one of the great medicines.
“I now have no tumors.”
Dallas Cowboys owner Jerry Jones sees an 18-game NFL regular season as something that will help the players financially and help teams grow fan bases.
Jones told the Morning News that he was diagnosed with cancer in June 2010 and began treatment at MD Anderson Cancer Center in Houston soon after. In the decade that followed, Jones said, he underwent lung surgery twice and lymph node surgery two times as well.
He did not indicate when he began the PD-1 therapy.
According to the American Cancer Society, PD-1 is a protein that acts as an “off switch” to keep certain immune cells — T cells — from attacking normal cells. PD-1 inhibitor therapy blocks this protein to help the immune system better find and attack cancer cells.
Nevada’s high court rules that former coach and TV analyst Jon Gruden’s lawsuit against the NFL can’t be forced into arbitration overseen by commissioner Roger Goodell.
Jones, 82, serves as the Cowboys’ president and general manager in addition to his role as owner. The first public mention of his diagnosis appears to have come during Episode 5 of the Netflix docuseries “America’s Team: The Gambler and His Cowboys,” which will be released Tuesday.
While telling an anecdote about a completely different subject — his relationship with former Cowboys coach Jimmy Johnson — Jones casually mentions that “12 or so years ago ... I had some cancer treatment” at MD Anderson.
The Morning News followed up on that comment during its wider-range interview with Jones.
